CPT code 55705 covers non–image-guided prostate tissue sampling performed to diagnose or evaluate prostate cancer and other prostatic disease. Nationally, this CPT code represents a common urologic diagnostic procedure that affects surgical practice patterns, billing workflows, and payer coverage determinations. Accurate coding for 55705 matters for clinical documentation, resource utilization tracking, and claims adjudication.

Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of what 55705 represents clinically, how it is typically delivered (service settings and provider specialty), and an overview of the billing context. The publication also summarizes typical modifiers observed with this service and highlights related policy and coverage considerations that influence reimbursement and prior authorization practices.

This summary provides clinicians, billing professionals, and policy analysts with benchmarks for coding practice, common payer considerations, and the clinical context for non–image-guided prostate biopsy. Data not available in the input is noted where applicable.